menu
    • menu

    Company profile for Vaxart

    NEW Drugs in Dev: 20
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is the promotion of global health through the development of effective vaccines that can be administered by tablet rather than by injection, providing for the simple and efficient distribution and administration of safe vaccines in any setting.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VaxartUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    385 Oyster Point Blvd., Suite 9A South San Francisco, CA 94080
    Telephone
    Telephone
    +1 650 550 3500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vaxart.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PCHi

    PCHi

    Not Confirmed

    envelop Contact Supplier

    PCHi

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vaxart Updates Business And Reveals 2025 Financial Results
    Vaxart Updates Business And Reveals 2025 Financial Results

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255120/25416/en/Vaxart-Provides-Business-Update-and-Reports-Full-Year-2025-Financial-Results.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Vaxart To Host Upcoming Conference Calls
    Vaxart To Host Upcoming Conference Calls

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248893/25416/en/Vaxart-to-Host-Upcoming-Conference-Calls.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Vaxart To Present At Oppenheimer Healthcare Life Sciences
    Vaxart To Present At Oppenheimer Healthcare Life Sciences

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240149/25416/en/Vaxart-to-Present-at-the-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference-on-February-25-2026.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Does Vaxart Hold The Key To The Elusive Norovirus Vaccine?
    Does Vaxart Hold The Key To The Elusive Norovirus Vaccine?

    17 Feb 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/does-vaxart-hold-the-key-to-the-elusive-norovirus-vaccine

    BIOSPACE
    17 Feb 2026
    Share Share
    Vaxart Releases Positive Data On Oral Norovirus Vaccine
    Vaxart Releases Positive Data On Oral Norovirus Vaccine

    15 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219496/25416/en/Vaxart-Publishes-Positive-Data-for-its-Oral-Bivalent-Norovirus-Candidate-in-Lactating-Women-and-Their-Infants.html

    GLOBENEWSWIRE
    15 Jan 2026
    Share Share
    Vaxart Joins Global Bioinnovation Forum On Jan 13, 2026
    Vaxart Joins Global Bioinnovation Forum On Jan 13, 2026

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215773/25416/en/Vaxart-to-Participate-in-the-Global-BioInnovation-Forum-on-January-13-2026.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search